AstraZeneca PLC - Common Stock - Foreign

Historical Holders from Q1 2014 to Q3 2025

CUSIP
000989529
Type / Class
Equity / Common Stock - Foreign
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
25.8K
Holdings value
$3.58M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
2
Number of buys
1
Average Value change %
+0%
Average buys %
+0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AstraZeneca PLC - Common Stock - Foreign

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 15.9K $2.39M +$58.5K $150.39 1
2025 Q2 25.8K $3.58M +$2.13M $138.80 2
2025 Q1 10.5K $1.52M -$954K $145.32 2
2024 Q4 17.7K $2.33M +$718K $131.10 3
2024 Q3 12.3K $1.91M +$5.11K $155.18 2
2024 Q2 12.2K $1.91M -$344K $156.19 2
2024 Q1 14.4K $1.95M -$104K $134.84 2
2023 Q4 15.2K $2.05M -$30.4K $135.13 1
2023 Q3 15.4K $2.09M +$2.09M $135.51 1
2023 Q1 0 $0 -$1.07M 0
2022 Q4 7.91K $1.07M +$136K $134.94 1
2022 Q3 6.9K $766K $0 $111.00 1
2022 Q2 6.9K $905K -$498K $131.16 1
2022 Q1 10.7K $1.43M $0 $133.40 1
2021 Q4 10.7K $1.26M $0 $117.54 1
2021 Q3 10.7K $1.29M +$1.29M $120.79 1
2015 Q3 0 $0 -$66.9M 0
2015 Q2 1.06M $66.9M -$81.5M $63.21 1
2015 Q1 2.35M $161M +$118M $68.68 1
2014 Q4 625K $44.4M +$44.4M $71.03 1
2014 Q2 8.85K $657 $0 $0.07 1
2014 Q1 0 $0 -$480K 0